CEA

Product Description

The Biorex Diagnostics Carcinoembryonic Antigen (CEA) CLIA Kit is a quantitative microplate chemiluminescence immunoassay designed for the accurate determination of CEA concentrations in human serum. This assay provides a reliable laboratory solution for oncology diagnostics, disease monitoring, and clinical research applications where precise biomarker measurement is essential.

Carcinoembryonic antigen is a glycoprotein involved in cell adhesion and is normally present at very low concentrations in healthy adults. Elevated serum levels are commonly associated with a variety of malignancies, particularly cancers of the gastrointestinal tract such as colorectal, pancreatic, and gastric tumours. Increased concentrations may also be observed in other malignancies, including lung and breast cancer, as well as certain benign conditions. Quantitative measurement is therefore widely used to support cancer diagnosis, evaluate disease progression, and monitor patient response to therapy.

The Biorex Diagnostics CEA CLIA Kit utilises a solid-phase chemiluminescent immunoassay methodology, offering high analytical sensitivity and specificity across clinically relevant concentration ranges. The chemiluminescent detection system enables accurate signal measurement with low background interference, supporting reliable interpretation of results. The assay is optimised to deliver consistent performance across multiple testing runs and laboratory environments, ensuring dependable reproducibility.

Designed with laboratory efficiency in mind, the kit includes ready-to-use reagents, calibrators, and controls, reducing preparation time and minimising technical variability. Compatibility with standard microplate CLIA instrumentation allows seamless integration into routine diagnostic workflows, making the assay suitable for both high-throughput clinical laboratories and specialised oncology testing facilities.

Key Features and Benefits

• Quantitative CLIA Microplate Assay: Enables precise measurement of serum tumour marker concentrations
• High Sensitivity and Specificity: Supports accurate detection in oncology diagnostics and monitoring
• Reliable Reproducibility: Ensures consistent results across laboratories and assay runs
• Ready-to-Use Components: Streamlines workflow and reduces hands-on time
• Versatile Clinical and Research Use: Suitable for diagnosis, prognosis, therapy monitoring, and biomarker research

The Biorex Diagnostics CEA CLIA Kit provides a trusted, accurate, and efficient solution for laboratories performing tumour marker analysis. By supporting early detection, treatment monitoring, and ongoing clinical evaluation, this assay contributes to informed clinical decision-making, improved patient management, and advanced oncology research.

Contact Us for more information.